News
AOP Orphan hosted an Experts Press Conference at DGHO in Berlin
7. 10. 2019AOP Orphan hosted Industry Symposium at DGHO in Berlin
7. 10. 2019AOP Orphan Pharmaceuticals AG, AOP Orphan IP AG and orphanix GmbH join forces to develop RetinolX to prevent bronchopulmonary dysplasia
13. 5. 2019
Meet Us Globally
- 23Mar.
Bio-Europe Spring 2020
PARIS, FRANCE - 4Apr.
11th European Narcolepsy Day
BERLIN, GERMANy - 6May.
Outsourcing in Clinical Trials
PARIS, FRANCE
Meet Us in Middle East
- 13Feb.
13th Annual Conference of the Saudi Association for Pulmonary Hypertension
RIYADH, SAUDI ARABIA - 19Mar.
3rd Congress of the Pulmonary Vascular Diseases Research Association, Pulmonary Hypertension 2020
ISTANBUL, TURKEY - 21Oct.
Euro-Asian Hematology & Oncolgy Congress
ISTANBUL, TURKEy
From the Concept to the Drug
AOP Orphan team covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.
Partnering
Partnering is of key importance for AOP Orphan. It allows further developing AOP Orphan’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe.
Join AOP Orphan
AOP Orphan team develops and investigates therapy options for patients with rare diseases – commitment and appreciation are the essence of our cooperative work.